Fuller & Thaler Asset Management’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
Other funds holding SRDX
TI
RA
Fuller & Thaler Asset Management's SRDX Position: Q1 2021 in Review
Fuller & Thaler Asset Management sold out of Surmodics (SRDX) in Q1 2021, closing a stake of 32,317 shares — an estimated $1.41M sold.
Fuller & Thaler Asset Management first reported a position in SRDX in Q2 2013 and held it in 16 quarters. The position peaked at $2.64M in Q3 2013. 138 funds tracked by Wall St. Rank hold SRDX as of Q1 2021.
- Fuller & Thaler Asset Management reported no remaining Surmodics position as of Q1 2021 after selling out during the quarter.
- Fuller & Thaler Asset Management sold 32,317 Surmodics shares in Q1 2021, an estimated $1.41M.
- Fuller & Thaler Asset Management first reported a position in Surmodics in Q2 2013 and held it in 16 quarters.
- Fuller & Thaler Asset Management's Surmodics position peaked at $2.64M in Q3 2013.
- 138 funds tracked by Wall St. Rank held Surmodics as of Q1 2021.
Based on Fuller & Thaler Asset Management's 13F filing for Q1 2021, filed 13 May 2021.